These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31471437)

  • 1. Outcome reporting from clinical trials of non-valvular atrial fibrillation treated with traditional Chinese medicine or Western medicine: a systematic review.
    Qiu R; Hu J; Huang Y; Han S; Zhong C; Li M; He T; Lin Y; Guan M; Chen J; Shang H
    BMJ Open; 2019 Aug; 9(8):e028803. PubMed ID: 31471437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a core outcome set (COS) and selecting outcome measurement instruments (OMIs) for non-valvular atrial fibrillation in traditional Chinese medicine clinical trials: study protocol.
    Qiu R; Li M; Zhang X; Chen S; Li C; Shang H
    Trials; 2018 Oct; 19(1):541. PubMed ID: 30290840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
    Lafuente-Lafuente C; Valembois L; Bergmann JF; Belmin J
    Cochrane Database Syst Rev; 2015 Mar; (3):CD005049. PubMed ID: 25820938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct oral anticoagulants in the early phase of non valvular atrial fibrillation-related acute ischemic stroke: focus on real life studies.
    Masotti L; Grifoni E; Dei A; Vannucchi V; Moroni F; Panigada G; Spolveri S; Landini G
    J Thromb Thrombolysis; 2019 Feb; 47(2):292-300. PubMed ID: 30470967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.
    Shepherd J; Jones J; Frampton GK; Tanajewski L; Turner D; Price A
    Health Technol Assess; 2008 Jun; 12(28):iii-iv, ix-95. PubMed ID: 18547499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin Compared to Low Intensity Anticoagulation in Patients with Non-Valvular Atrial Fibrillation. A Systematic Review and Meta-Analysis.
    Vazquez FJ; Gonzalez JP; Gándara E
    PLoS One; 2015; 10(11):e0142222. PubMed ID: 26561858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF).
    Sun Y; Zhu J; Ma C; Liu S; Yang Y; Hu D
    Cardiovasc Ther; 2019; 2019():7372129. PubMed ID: 31772614
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral traditional Chinese medication for adhesive small bowel obstruction.
    Suo T; Gu X; Andersson R; Ma H; Zhang W; Deng W; Zhang B; Cai D; Qin X
    Cochrane Database Syst Rev; 2012 May; (5):CD008836. PubMed ID: 22592734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Jonas DE; Kahwati LC; Yun JDY; Middleton JC; Coker-Schwimmer M; Asher GN
    JAMA; 2018 Aug; 320(5):485-498. PubMed ID: 30088015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rate versus rhythm control in atrial fibrillation and clinical outcomes: updated systematic review and meta-analysis of randomized controlled trials.
    Caldeira D; David C; Sampaio C
    Arch Cardiovasc Dis; 2012 Apr; 105(4):226-38. PubMed ID: 22633297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.
    Bhat Y; Dixit A; Mistri A; Patel B; Quoraishi SH; Uprichard J
    BMC Neurol; 2019 Nov; 19(1):306. PubMed ID: 31783738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks.
    Benavente O; Hart R; Koudstaal P; Laupacis A; McBride R
    Cochrane Database Syst Rev; 2000; (2):CD001927. PubMed ID: 10796453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid evidence assessment of bleed-related healthcare resource utilization in publications reporting the use of direct oral anticoagulants for non-valvular atrial fibrillation.
    Shah BR; Scholtus E; Rolland C; Batscheider A; Katz JN; Nilsson KR
    Curr Med Res Opin; 2019 Jan; 35(1):127-139. PubMed ID: 30380959
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anticoagulation with atrial fibrillation].
    Zellerhoff S; Goette A; Kirchhof P
    Herzschrittmacherther Elektrophysiol; 2006 Jun; 17(2):89-94. PubMed ID: 16786467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Ntaios G; Papavasileiou V; Makaritsis K; Vemmos K; Michel P; Lip GYH
    Stroke; 2017 Sep; 48(9):2494-2503. PubMed ID: 28716982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes of Rate vs Rhythm Control for Atrial Fibrillation in Older People: A Systematic Review and Meta-Analysis.
    Depoorter L; Sels L; Deschodt M; Van Grootven B; Van der Linden L; Tournoy J
    Drugs Aging; 2020 Jan; 37(1):19-26. PubMed ID: 31745834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.
    Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P
    Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic Cardiomyopathy in Patients with Atrial Fibrillation: Prevalence and Associated Stroke Risks in a Nationwide Cohort Study.
    Jung H; Yang PS; Sung JH; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Thromb Haemost; 2019 Feb; 119(2):285-293. PubMed ID: 30602200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.